{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:47:34Z","timestamp":1788518854777,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00345-020-03364-z","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T07:03:32Z","timestamp":1595315012000},"page":"1917-1926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-8939","authenticated-orcid":false,"given":"Richard","family":"Naspro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Finati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roscigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pellucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"La Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sodano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Manica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Chinaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi F.","family":"Da Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"key":"3364_CR1","first-page":"335","volume":"35","author":"M Moschini","year":"2017","unstructured":"Moschini M, Dell\u2019Oglio P, Luciano R et al (2017) Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy. Urol Oncol Semin Orig Investig 35:335\u2013341","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"6 Suppl 4","key":"3364_CR2","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.5489\/cuaj.1195","volume":"3","author":"V Chalasani","year":"2009","unstructured":"Chalasani V, Chin JL, Izawa JI (2009) Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J 3(6 Suppl 4):S193\u2013S198. https:\/\/doi.org\/10.5489\/cuaj.1195","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"3364_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part b: prostate and bladder tumours. Eur Urol 70(1):106\u2013119. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"issue":"1","key":"3364_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.urolonc.2007.07.010","volume":"27","author":"PC Black","year":"2009","unstructured":"Black PC, Brown GA, Dinney CP (2009) The impact of variant histology on the outcome of bladder cancer treated with curative intent. Urol Oncol 27(1):3\u20137. https:\/\/doi.org\/10.1016\/j.urolonc.2007.07.010","journal-title":"Urol Oncol"},{"key":"3364_CR5","doi-asserted-by":"crossref","unstructured":"Motterle G, Andrews JR, Morlacco A, Karnes RJ (2019) Predicting response to neoadjuvant chemotherapy in bladder cancer. Eur Urol Focus Elsevier B.V.","DOI":"10.1016\/j.euf.2019.10.016"},{"key":"3364_CR6","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1002\/cncr.30907","volume":"123","author":"MW Vetterlein","year":"2017","unstructured":"Vetterlein MW, Wankowicz SAM, Seisen T et al (2017) Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology. Cancer 123:4346\u20134355","journal-title":"Cancer"},{"issue":"1","key":"3364_CR7","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1016\/j.clgc.2015.09.013","volume":"14","author":"VK Pokuri","year":"2016","unstructured":"Pokuri VK, Syed JR, Yang Z et al (2016) Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma. Clin Genitourin Cancer 14(1):e59\u2013e65. https:\/\/doi.org\/10.1016\/j.clgc.2015.09.013","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"3364_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.eururo.2019.10.026","volume":"77","author":"A Necchi","year":"2020","unstructured":"Necchi A, Raggi D, Gallina A et al (2020) Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies. Eur Urol 77(4):439\u2013446. https:\/\/doi.org\/10.1016\/j.eururo.2019.10.026","journal-title":"Eur Urol"},{"key":"3364_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2019.09.003","author":"E Veskim\u00e4e","year":"2019","unstructured":"Veskim\u00e4e E et al (2019) What is the prognostic and clinical importance of urothelial and nonurothelial histological variants of bladder cancer in predicting oncological outcomes in patients with muscle-invasive and metastatic bladder cancer? A European association of urology muscle invasive and metastatic bladder cancer guidelines panel systematic review European urology oncology. NLM (Medline). https:\/\/doi.org\/10.1016\/j.euo.2019.09.003","journal-title":"NLM (Medline)"},{"issue":"4","key":"3364_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.eururo.2017.12.018","volume":"73","author":"GP Paner","year":"2018","unstructured":"Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB (2018) Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol 73(4):560\u2013569. https:\/\/doi.org\/10.1016\/j.eururo.2017.12.018","journal-title":"Eur Urol"},{"issue":"5","key":"3364_CR11","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.eururo.2011.07.012","volume":"60","author":"RP Dorin","year":"2011","unstructured":"Dorin RP, Daneshmand S, Eisenberg MS et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60(5):946\u2013952. https:\/\/doi.org\/10.1016\/j.eururo.2011.07.012","journal-title":"Eur Urol"},{"key":"3364_CR12","unstructured":"EAU Guidelines Office, Arnhem, The Netherlands. https:\/\/uroweb.org\/guideline\/bladder-cancer-muscle-invasive-and-metastatic\/ accessed 14 April 2020"},{"key":"3364_CR13","first-page":"252","volume":"30","author":"JC Wheat","year":"2012","unstructured":"Wheat JC, Weizer AZ, Wolf JS et al (2012) Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. Urol Oncol Semin Orig Investig 30:252\u2013258","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"3364_CR14","doi-asserted-by":"publisher","first-page":"6533","DOI":"10.1200\/JCO.2005.05.516","volume":"23","author":"Y Lotan","year":"2005","unstructured":"Lotan Y, Gupta A, Shariat SF et al (2005) Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23:6533\u20136539","journal-title":"J Clin Oncol"},{"issue":"6","key":"3364_CR15","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.juro.2010.02.021","volume":"183","author":"G Novara","year":"2010","unstructured":"Novara G, Svatek RS, Karakiewicz PI et al (2010) Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4400 patients. J Urol 183(6):2165\u20132170. https:\/\/doi.org\/10.1016\/j.juro.2010.02.021","journal-title":"J Urol"},{"key":"3364_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.09.003","author":"N Lobo","year":"2019","unstructured":"Lobo N, Shariat SF, Guo CC et al (2019) What Is the significance of variant histology in urothelial carcinoma? Eur Urol Focus Press. https:\/\/doi.org\/10.1016\/j.euf.2019.09.003","journal-title":"Eur Urol Focus Press"},{"issue":"2","key":"3364_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/106689690501300203","volume":"13","author":"R Montironi","year":"2005","unstructured":"Montironi R, Lopez-Beltran A (2005) The 2004 WHO classification of bladder tumors: a summary and commentary. Int J Surg Pathol 13(2):143\u2013153. https:\/\/doi.org\/10.1177\/106689690501300203","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"3364_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1046\/j.1464-410x.2000.00614.x","volume":"85","author":"J Leissner","year":"2000","unstructured":"Leissner J, Hohenfellner R, Th\u00fcroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85(7):817\u2013823. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00614.x","journal-title":"BJU Int"},{"key":"3364_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.08.001","author":"EE van de Fransen Putte","year":"2015","unstructured":"van de Fransen Putte EE, Hermans TJ, Werkhoven Ev et al (2015) Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2015.08.001(33(12): 504.e19\u2013504.e5.04E24)","journal-title":"Urol Oncol"},{"issue":"8","key":"3364_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.ejca.2013.02.001","volume":"49","author":"E Xylinas","year":"2013","unstructured":"Xylinas E, Rink M, Robinson BD et al (2013) Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. Eur J Cancer 49(8):1889\u20131897. https:\/\/doi.org\/10.1016\/j.ejca.2013.02.001","journal-title":"Eur J Cancer"},{"issue":"1","key":"3364_CR21","doi-asserted-by":"publisher","first-page":"21.e1","DOI":"10.1016\/j.urolonc.2014.10.013","volume":"33","author":"A Soave","year":"2015","unstructured":"Soave A, Schmidt S, Dahlem R et al (2015) Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy? Urol Oncol 33(1):21.e1\u201321.e9. https:\/\/doi.org\/10.1016\/j.urolonc.2014.10.013","journal-title":"Urol Oncol"},{"issue":"6","key":"3364_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.clgc.2015.05.001","volume":"13","author":"J Molina-Cerrillo","year":"2015","unstructured":"Molina-Cerrillo J, Mart\u00ednez-S\u00e1ez O, Alonso-Gordoa T et al (2015) Primary sarcomatoid tumor of the bladder: a different entity but the same approach? Clin Genitourin Cancer 13(6):493\u2013498. https:\/\/doi.org\/10.1016\/j.clgc.2015.05.001","journal-title":"Clin Genitourin Cancer"},{"key":"3364_CR23","doi-asserted-by":"publisher","first-page":"454792","DOI":"10.1155\/2010\/454792","volume":"2010","author":"J Wang","year":"2010","unstructured":"Wang J, Wang FW, Lagrange CA, Hemstreet GP III, Kessinger A (2010) Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases. Sarcoma 2010:454792. https:\/\/doi.org\/10.1155\/2010\/454792","journal-title":"Sarcoma"},{"issue":"1","key":"3364_CR24","doi-asserted-by":"publisher","first-page":"107327481880026","DOI":"10.1177\/1073274818800269","volume":"25","author":"A Minato","year":"2018","unstructured":"Minato A, Noguchi H, Tomisaki I et al (2018) Clinical significance of squamous differentiation in urothelial carcinoma of the bladder. Cancer Control 25(1):1073274818800269","journal-title":"Cancer Control"},{"issue":"2","key":"3364_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.urolonc.2012.08.017","volume":"32","author":"AP Mitra","year":"2014","unstructured":"Mitra AP, Bartsch CC, Bartsch G Jr, Miranda G, Skinner EC, Daneshmand S (2014) Does presence of squamous and glandular differentiation in urothelial carcinoma of the bladder at cystectomy portend poor prognosis? An intensive case-control analysis. Urol Oncol 32(2):117\u2013127. https:\/\/doi.org\/10.1016\/j.urolonc.2012.08.017","journal-title":"Urol Oncol"},{"issue":"10","key":"3364_CR26","doi-asserted-by":"publisher","first-page":"425.e7","DOI":"10.1016\/j.urolonc.2015.06.011","volume":"33","author":"JP Izard","year":"2015","unstructured":"Izard JP, Siemens DR, Mackillop WJ et al (2015) Outcomes of squamous histology in bladder cancer: a population-based study. Urol Oncol 33(10):425.e7\u2013425.e13. https:\/\/doi.org\/10.1016\/j.urolonc.2015.06.011","journal-title":"Urol Oncol"},{"key":"3364_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humpath.2018.05.005","volume":"79","author":"G Wang","year":"2018","unstructured":"Wang G, Xiao L, Zhang M et al (2018) Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol 79:57\u201365. https:\/\/doi.org\/10.1016\/j.humpath.2018.05.005","journal-title":"Hum Pathol"},{"issue":"Suppl 2","key":"3364_CR28","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1038\/modpathol.2009.26","volume":"22","author":"MB Amin","year":"2009","unstructured":"Amin MB (2009) Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications. Mod Pathol 22(Suppl 2):S96\u2013S118. https:\/\/doi.org\/10.1038\/modpathol.2009.26","journal-title":"Mod Pathol"},{"issue":"3 Pt 1","key":"3364_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0022-5347(05)00423-4","volume":"175","author":"AM Kamat","year":"2006","unstructured":"Kamat AM, Gee JR, Dinney CP et al (2006) The case for early cystectomy in the treatment of non muscle invasive micropapillary bladder carcinoma. J Urol 175(3 Pt 1):881\u2013885. https:\/\/doi.org\/10.1016\/S0022-5347(05)00423-4(published correction appears in J Urol. 2006 May; 175(5): 1967)","journal-title":"J Urol"},{"issue":"4","key":"3364_CR30","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1464-410X.2011.10357.x","volume":"109","author":"F Abdollah","year":"2012","unstructured":"Abdollah F, Sun M, Jeldres C et al (2012) Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs. urothelial carcinoma: a competing-risks analysis. BJU Int 109(4):564\u2013569. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10357.x","journal-title":"BJU Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03364-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:31:58Z","timestamp":1626823918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03364-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3364"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03364-z","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr Richard Naspro received speakers honoraria from Ipsen. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}